Abstract
Background/Objectives
The evidence for diet as a risk factor for multiple sclerosis (MS) is inconclusive. We examined the associations between fish consumption and risk of a first clinical diagnosis of central nervous system demyelination (FCD), a common precursor to MS.
Methods
The 2003–2006 Ausimmune Study was a case-control study examining environmental risk factors for FCD, with participants recruited from four regions of Australia and matched on age, sex, and study region. Dietary intake data were collected using a food frequency questionnaire. We used conditional logistic regression models to test associations between fish consumption (total, tinned, grilled, and fried) and risk of FCD (249 cases and 438 controls), adjusting for history of infectious mononucleosis, smoking, serum 25-hydroxyvitamin D concentrations, socio-economic status, omega-3 supplement use, dietary under-reporting, and total energy intake.
Results
Higher total fish consumption (per 30 g/day, equivalent to two serves/week) was associated with an 18% reduced risk of FCD (AOR 0.82; 95% CI 0.70, 0.97). While we found no statistically significant associations between grilled and fried fish consumption and risk of FCD, higher tinned fish consumption (per 30 g/day) was associated with a 41% reduced risk of FCD (AOR 0.59; 95% CI 0.39, 0.89).
Conclusions
Tinned fish is predominantly oily, whereas grilled and fried fish are likely to be a combination of oily and white types. Oily fish is high in vitamin D and very long chain polyunsaturated omega-3 fatty acids, both of which may be beneficial in relation to MS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378:169–80.
O’Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci. 2012;13:11718–52.
Lauer K. Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits. Int J Mol Sci. 2014;15:3533–45.
Mandia D, Ferraro O, Nosari G, Montomoli C, Zardini E, Bergamaschi R. Environmental factors and multiple sclerosis severity: a descriptive study. Int J Environ Res Public Health. 2014;11:6417.
Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7. https://doi.org/10.1177/1759091414568185.
Jahromi SR, Toghae M, Jahromi MJ, Aloosh M. Dietary pattern and risk of multiple sclerosis. Iran J Neurol. 2012;11:47–53.
Sedaghat F, Jessri M, Behrooz M, Mirghotbi M, Rashidkhani B. Mediterranean diet adherence and risk of multiple sclerosis: a case-control study. Asia Pac J Clin Nutr. 2016;25:377–84.
Baarnhielm M, Olsson T, Alfredsson L. Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler J. 2014;20:726–32.
Black LJ, Rowley C, Sherriff J, Pereira G, Ponsonby A-L, Ausimmune Investigator Group et al. A healthy dietary pattern associates with a lower risk of a first clinical diagnosis of central nervous system demyelination. Mult Scler J. 2018. https://doi.org/10.1177/1352458518793524.
Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol. 2007;254:471–7.
Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol. 1998;27:845–52.
Liu J, Arcot J, Cunningham J, Greenfield H, Hsu J, Padula D, et al. New data for vitamin D in Australian foods of animal origin: impact on estimates of national adult vitamin D intakes in 1995 and 2011–13. Asia Pac J Clin Nutr. 2015;24:464–71.
Meyer BJ. Australians are not meeting the recommended intakes for omega-3 long chain polyunsaturated fatty acids: results of an analysis from the 2011-2012 National Nutrition and Physical Activity Survey. Nutrients. 2016;8:111.
DeFilippis AP, Sperling LS. Understanding omega-3s. Am Heart J. 2006;151:564–70.
Lucas R, Ponsonby AL, McMichael A, van der Mei I, Chapman C, Coulthard A, et al. Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function. Mult Scler J. 2007;13:827–39.
Lucas RM, Ponsonby A-L, Dear K, Valery PC, Pender MP, Taylor BV, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology. 2011;76:540–8.
Hoare S, Lithander F, van der Mei I, Ponsonby AL, Lucas R. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the Ausimmune Study. Mult Scler J. 2016;22:884–92.
Black LJ, Bowe GS, Pereira G, Lucas RM, Dear K, van der Mei I, et al. Higher non-processed red meat consumption is associated with a reduced risk of central nervous system demyelination. Front Neurol. 2019;10:125.
Cancer Council Victoria. Dietary questionnaire for epidemiological studies (DQES v2) user information guide. Victoria, Australia: Carlton; 2009.
Ireland P, Jolley D, Giles G, O’Dea K, Powles J, Rutishauser I, et al. Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr. 1994;3:19–31.
Australian Bureau of Statistics. Census of Population and Housing, 2006. http://www.abs.gov.au. Accessed 24 Jan 2019.
Harris J, Benedict F. A biometric study of basal metabolism in man. Washington D.C.: Carnegie Institute of Washington; 1919.
Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR, Coward WA, et al. Critical evaluation of energy intake data using fundamental principles of energy physiology: derivation of cut-off limits to identify under-reporting. Eur J Clin Nutr. 1991;45:569–81.
Willett W. Nutritional epidemiology. 3rd ed New York: Oxford University Press; 2013.
Ambrosini GL, Fritschi L, de Klerk NH, Mackerras D, Leavy J. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia. Ann Epidemiol. 2008;18:364–70.
Emsley R, Liu H. Stata module to perform causal mediation analysis using parametric regression models, 2013. https://ideas.repec.org/c/boc/bocode/s457581.html. Accessed 16 Feb 2019.
StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015.
Australian Government Department of Health. Lean Meat and poultry, fish, eggs, tofu, nuts and seeds and legumes/beans, 2017. https://www.eatforhealth.gov.au/food-essentials/five-food-groups/lean-meat-and-poultry-fish-eggs-tofu-nuts-and-seeds-and. Accessed 24 Jan 2019.
Allen MJ, Fan YY, Monk JM, Hou TY, Barhoumi R, McMurray DN, et al. n-3 PUFAs reduce T-helper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4(+) T cells. J Nutr. 2014;144:1306–13.
Shinto L, Marracci G, Bumgarner L, Yadav V. The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis. Autoimmune Dis. 2011;2011:134592.
Liuzzi GM, Latronico T, Rossano R, Viggiani S, Fasano A, Riccio P. Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells-implications for complementary multiple sclerosis treatment. Neurochem Res. 2007;32:2184–93.
Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res. 1999;56:565–70.
Jones CR, Arai T, Rapoport SI. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem Res. 1997;22:663–70.
Kaur G, Guo XF, Sinclair AJ. Short update on docosapentaenoic acid: a bioactive long-chain n-3 fatty acid. Curr Opin Clin Nutr Metab Care. 2016;19:88–91.
Ramirez-Ramirez V, Macias-Islas MA, Ortiz GG, Pacheco-Moises F, Torres-Sanchez ED, Sorto-Gomez TE, et al. Efficacy of fish oil on serum of TNF alpha, IL-1 beta, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid Med Cell Longev. 2013;2013:709493.
Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, Shaw DA, et al. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989;52:18–22.
Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, et al. omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012;69:1044–51.
Gormley T, Neumann T, Fagan J, Brunton N. Taurine content of raw and processed fish fillets/portions. Eur Food Res Technol. 2007;225:837–42.
Tørris C, Småstuen MC, Molin M. Nutrients in fish and possible associations with cardiovascular disease risk factors in metabolic syndrome. Nutrients. 2018;10:E952.
Wójcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y. The potential protective effects of taurine on coronary heart disease. Atherosclerosis. 2010;208:19–25.
Jakaria M, Azam S, Haque ME, Jo S-H, Uddin MS, Kim I-S, et al. Taurine and its analogs in neurological disorders: focus on therapeutic potential and molecular mechanisms. Redox Biol. 2019;24:101223.
Che Y, Hou L, Sun F, Zhang C, Liu X, Piao F, et al. Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization. Cell Death Dis. 2018;9:435–435.
‘t Harst BA, Vogels JTWE, Spijksma G, Brok HPM, Polman C, van Der Greef J. 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. J Neurol Sci. 2003;212:21–30.
Beyer BA, Fang M, Sadrian B, Montenegro-Burke JR, Plaisted WC, Kok BPC, et al. Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation. Nat Chem Biol. 2017;14:22–31.
Black LJ, Anderson D, Clarke MW, Ponsonby A-L, Lucas RM, Ausimmune Investigator Group. Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D status in clinical and research settings. PLoS ONE. 2015;10:e0135478.
Black AE, Prentice AM, Goldberg GR, Jebb SA, Bingham SA, Livingstone MBE, et al. Measurements of total energy expenditure provide insights into the validity of dietary measurements of energy intake. J Am Diet Assoc. 1993;93:572–9.
Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016;9:211–7.
Ponsonby AL, Lucas RM, Dear K, van der Mei I, Taylor B, Chapman C, et al. The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study. Mult Scler J. 2013;19:1717–25.
Acknowledgements
We thank the participants of the Ausimmune Study. We would like to acknowledge and thank the physicians who notified case participants to the Ausimmune Study: Jeffrey Blackie FRACP, Richard Bourke FRACGP, John Cameron MD, Ross Carne MD, Ben Clark FRANZCO, Steven Collins MD, Diana Conrad FRANZCO, Michael Coroneos FRACS, Nicholas Downie FRANZCO, David Floate FRACP, Peter Gates FRACP, Kerryn Green FRACP, Erwin Groeneveld FRANZCO, John Harrison FRANZCO, Michael Haybittel FRANZCO, Robert Henderson FRACP, John Henshaw MMed, James Hurley MD, Dean Jones FRACP, Michael Katekar MBBS, Anthony Kemp FRACP, Mark King FRACP, George Kiroff FRACS, Brett Knight FRACP, Thomas Kraemer FRACP, Cecile Lander FRACP, Jeannette Lechner-Scott FRACP, Andre Loiselle FRACP, Paul McCartney FRANZCO, Pamela McCombe PhD, Mark McGree FRANZCO, David McKnight FRANZCO, Daniel McLaughlin PhD, Satish Nagarajah MBBS, Rob Nightingale FRACP, Terence O’Brien MD, John O'Sullivan MD, Gregory Outteridge FRANZCO, Anthony Pane FRANZCO, Mark Parsons FRACP, Melinda Pascoe FRACP, David Prentice PhD, Richard Ralph FRACGP, Stephen Read FRACP, John Richmond FRACP, Ian Routley FRANZCO, Timothy Ruddle FRANZCO, Noel Saines FRACP, Stan Siejka MBBS (dec), Christopher Staples FRACP, Paul Talman FRACP, Don Todman FRACP, Nitin Verma FRANZCO, Brendan Vote FRANZCO, Michael Waldie FRANZCO, Michael Weetch FRACP, Rodney Westmore FRANZCO, Andrew Wong FRACP; and the local research officers: Susan Agland BN, Barbara Alexander BN, Marcia Davis MD, Zoe Dunlop BN, Rosalie Scott BN, Marie Steele RN, Catherine Turner MPH&TM, Brenda Wood RN; and the Ausimmune Study project officers during the course of the study: Jane Gresham MA(Int Law), Camilla Jozwick BSc(Hons), Helen Rodgers RN.
Funding
Funding for the Ausimmune Study was provided by the National Multiple Sclerosis Society of the United States of America, the National Health and Medical Research Council of Australia and Multiple Sclerosis Research Australia. LJB is supported by a Multiple Sclerosis Western Australia Postdoctoral Fellowship and a Curtin University Research Fellowship. RML is supported by a National Health and Medical Research Council of Australia Senior Research Fellowship. Funding bodies had no role in the design or conduct of the study; collection, management, analysis, or interpretation of data; or preparation, review, or approval of the paper.
Author contributions
The Ausimmune Investigator Group and LJB designed the study; LJB analysed and interpreted the data and wrote the paper; YCP contributed to data analysis; GP provided statistical support and contributed to data interpretation; JLS, RML, GP, and the Ausimmune Investigator Group provided critical revision of the paper for important intellectual content; LJB had primary responsibility for the final content. All the authors read and approved the final version of the paper.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Black, L.J., Zhao, Y., Peng, Y.C. et al. Higher fish consumption and lower risk of central nervous system demyelination. Eur J Clin Nutr 74, 818–824 (2020). https://doi.org/10.1038/s41430-019-0476-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-019-0476-z
This article is cited by
-
Dietary Patterns and Their Associations with Symptom Levels Among People with Multiple Sclerosis: A Real-World Digital Study
Neurology and Therapy (2023)
-
Dietary Tyrosine Intake (FFQ) Is Associated with Locus Coeruleus, Attention and Grey Matter Maintenance: An MRI Structural Study on 398 Healthy Individuals of the Berlin Aging Study-II
The Journal of nutrition, health and aging (2023)
-
Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort
Neurological Sciences (2022)